Company intelligence / Profile preview

CONMED

Largo, Florida, United Statesin.marketscreener.com ↗

Ownership: Public · CNMD
Employees: ~4000
Development stage: Commercial

Overview

CONMED’s medical devices are widely adopted globally for minimally invasive surgeries. The company has a strong commercial presence with innovative products such as the AirSeal® insufflation system for laparoscopic procedures and BioBrace® soft tissue augmentation implant. Clinical studies have demonstrated benefits of their technologies—e.g., AirSeal® enables low-pressure peritoneum during laparoscopy to reduce surgical stress response[2].

Therapeutic areas: GastroenterologyPulmonologyRheumatologyOtherWomen's Health
Modalities: Device
Industry: Surgical Medical Devices

Partnerships

Musculoskeletal Transplant Foundation for sports medicine allograft tissues

Financials

Market cap: $1.4B
Total revenue: $343.5M
Enterprise value: $2.2B

Beyond the preview

Go deeper on CONMED.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CONMED.

Explore the full profile